BSEMBioStem Technologies, Inc.
Health Care
Accounts Receivable, Allowance for Credit Loss revised up 2.5% for Q2 2025
Accounts Receivable, Allowance for Credit Loss·As of Dec 31, 2025
Notable restatement$9M▲ 2.5%
was$8.8M
Revised up in a S-1.
No amendment filed
As reported · Aug 12, 2026S-1 · Oct 3, 2026us-gaap:AllowanceForDoubtfulAccountsReceivableVerify against SEC filingsShow
As reported$8.8M
Accepted 2026-08-120001193125-26-347096
Restated$9M
Accepted 2026-10-030001213900-26-106555
AllowanceForDoubtfulAccounts · reported 3 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time BSEM — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.